Page last updated: 2024-11-03

propentofylline and Aging

propentofylline has been researched along with Aging in 3 studies

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"Treatment with adrafinil resulted in a significant increase in locomotion in each of the open-field tests and an increase in locomotion in the home cage."2.69Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs. ( Gruet, P; Milgram, NW; Muggenburg, BA; Murphey, HL; Siwak, CT; Woehrlé, F, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nabeshima, T2
Nitta, A2
Fuji, K1
Kameyama, T1
Hasegawa, T2
Siwak, CT1
Gruet, P1
Woehrlé, F1
Muggenburg, BA1
Murphey, HL1
Milgram, NW1

Trials

1 trial available for propentofylline and Aging

ArticleYear
Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs.
    American journal of veterinary research, 2000, Volume: 61, Issue:11

    Topics: Adrenergic alpha-Antagonists; Aging; Animals; Behavior, Animal; Discrimination Learning; Dogs; Femal

2000

Other Studies

2 other studies available for propentofylline and Aging

ArticleYear
Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats.
    Gerontology, 1994, Volume: 40 Suppl 2

    Topics: Administration, Oral; Aging; Analysis of Variance; Animals; Benzoquinones; Brain; Choline O-Acetyltr

1994
Impairment of learning and memory and the accessory symptom in aged rat as senile dementia model (3): Oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats.
    Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1993, Volume: 13, Issue:3

    Topics: Administration, Oral; Aging; Alzheimer Disease; Animals; Brain; Choline O-Acetyltransferase; Disease

1993